Rani Therapeutics Holdings, Inc. (RANI) Net Income by Year
Rani Therapeutics Holdings, Inc. reported a net loss of $29.7M in fiscal year 2025. This represents an increase of 1.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Rani Therapeutics Holdings, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RANI Net Income by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
RANI Net Income by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What net income means
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.
More Rani Therapeutics Holdings, Inc. financials
Frequently Asked Questions
What was Rani Therapeutics Holdings, Inc.'s net income in fiscal year 2025?
Rani Therapeutics Holdings, Inc. reported a net loss of $29.7M in fiscal year 2025.
How fast is Rani Therapeutics Holdings, Inc.'s net income growing?
Rani Therapeutics Holdings, Inc. (RANI) net income rose by 1.1% year over year, from -$30.0M to -$29.7M in fiscal year 2025.
How has Rani Therapeutics Holdings, Inc.'s net income changed over the years?
Across the 6 fiscal years this page covers, Rani Therapeutics Holdings, Inc. (RANI) net income went from -$16.7M in fiscal year 2020 to -$29.7M in fiscal year 2025.
What was Rani Therapeutics Holdings, Inc.'s net income in the most recent quarter?
Rani Therapeutics Holdings, Inc. (RANI) reported -$7.4M in net income in Q2 2026. This represents a decrease of 10.4% from the same quarter a year earlier.
What does net income mean on a financial statement?
Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Rani Therapeutics Holdings, Inc. (RANI) reported on that line in every period on record.